Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

305.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 340.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 47.16m
  • Volume: 92,137
  • Market Cap: £143.85m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
86.69% below the market average86.69% below the market average86.69% below the market average86.69% below the market average86.69% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
1yr Revenue Growth
24.97% above the market average24.97% above the market average24.97% above the market average24.97% above the market average24.97% above the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
8.12% below the market average8.12% below the market average8.12% below the market average8.12% below the market average8.12% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average
Price Book Ratio
77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
25.03% above the market average25.03% above the market average25.03% above the market average25.03% above the market average25.03% above the market average
45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average
Price Chg 3m
74.26% above the market average74.26% above the market average74.26% above the market average74.26% above the market average74.26% above the market average
66.10% above the sector average66.10% above the sector average66.10% above the sector average66.10% above the sector average66.10% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
29.46% above the market average29.46% above the market average29.46% above the market average29.46% above the market average29.46% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average
Momentum 20
29.25% above the market average29.25% above the market average29.25% above the market average29.25% above the market average29.25% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
57.18% below the market average57.18% below the market average57.18% below the market average57.18% below the market average57.18% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
12.51% below the market average12.51% below the market average12.51% below the market average12.51% below the market average12.51% below the market average
51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average51.72% above the sector average
Forecast EPS
24.22% below the market average24.22% below the market average24.22% below the market average24.22% below the market average24.22% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
13.10% above the market average13.10% above the market average13.10% above the market average13.10% above the market average13.10% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Operating Profit Loss
84.57% below the market average84.57% below the market average84.57% below the market average84.57% below the market average84.57% below the market average
41.38% below the sector average41.38% below the sector average41.38% below the sector average41.38% below the sector average41.38% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
3.39% above the market average3.39% above the market average3.39% above the market average3.39% above the market average3.39% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Cash
17.87% below the market average17.87% below the market average17.87% below the market average17.87% below the market average17.87% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
97.26% below the market average97.26% below the market average97.26% below the market average97.26% below the market average97.26% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Buys 1y
82.21% above the market average82.21% above the market average82.21% above the market average82.21% above the market average82.21% above the market average
64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
40.86% above the market average40.86% above the market average40.86% above the market average40.86% above the market average40.86% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 305.00p
Change Today 1.00p
% Change 0.33 %
52 Week High 340.00
52 Week Low 147.50
Volume 92,137
Shares Issued 47.16m
Market Cap £143.85m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.85% below the market average31.85% below the market average31.85% below the market average31.85% below the market average31.85% below the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average
Price Trend
97.99% above the market average97.99% above the market average97.99% above the market average97.99% above the market average97.99% above the market average
93.22% above the sector average93.22% above the sector average93.22% above the sector average93.22% above the sector average93.22% above the sector average
Income Not Available
Growth
42.87% below the market average42.87% below the market average42.87% below the market average42.87% below the market average42.87% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 11-Oct-2019

Time Volume / Share Price
16:16 7,500 @ 304.00p
16:08 2,000 @ 306.20p
15:42 5,000 @ 305.00p
15:42 3,000 @ 305.00p
15:28 4,911 @ 307.00p

Top of Page